sb 202190 has been researched along with Cardiovascular Diseases in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ElKeeb, AM | 1 |
| Collier, ME | 1 |
| Maraveyas, A | 1 |
| Ettelaie, C | 1 |
1 other study available for sb 202190 and Cardiovascular Diseases
| Article | Year |
|---|---|
Accumulation of tissue factor in endothelial cells induces cell apoptosis, mediated through p38 and p53 activation.
Topics: Amino Acid Substitution; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cardiovascular Dis | 2015 |